{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:48:54Z","timestamp":1793134134664,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2025,7,27]],"date-time":"2025-07-27T00:00:00Z","timestamp":1753574400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,27]],"date-time":"2025-07-27T00:00:00Z","timestamp":1753574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"crossref","award":["CER-1503-29572"],"award-info":[{"award-number":["CER-1503-29572"]}],"id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1245\/s10434-025-17915-4","type":"journal-article","created":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T22:27:12Z","timestamp":1753568832000},"page":"9776-9786","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Patient-reported Outcomes After Routine Treatment of In Situ\/Atypical Lesions: The PORTAL Study"],"prefix":"10.1245","volume":"32","author":[{"given":"Shoshana M.","family":"Rosenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christel","family":"Rushing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin L.","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerri-Anne","family":"Crowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Bedrosian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin S.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desiree","family":"Basila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Collyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth S.","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Darai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conor","family":"Lanahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey R.","family":"Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer K.","family":"Plichta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry","family":"Hyslop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair M.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann H.","family":"Partridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Shelley","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,27]]},"reference":[{"key":"17915_CR1","unstructured":"American Cancer Society. Breast Cancer Facts & Figures 2022-2024. American Cancer Society, Inc.; 2022."},{"issue":"4","key":"17915_CR2","doi-asserted-by":"publisher","first-page":"pky063","DOI":"10.1093\/jncics\/pky063","volume":"2","author":"RS Punglia","year":"2018","unstructured":"Punglia RS, Bifolck K, Golshan M, et al. Epidemiology, biology, treatment, and prevention of ductal carcinoma in situ (DCIS). JNCI Cancer Spectr. 2018;2(4):pky063. https:\/\/doi.org\/10.1093\/jncics\/pky063.","journal-title":"JNCI Cancer Spectr"},{"issue":"2","key":"17915_CR3","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s10549-005-9101-z","volume":"97","author":"B Erbas","year":"2006","unstructured":"Erbas B, Provenzano E, Armes J, Gertig D. The natural history of ductal carcinoma in situ of the breast: a review. Breast Cancer Res Treat. 2006;97(2):135\u201344. https:\/\/doi.org\/10.1007\/s10549-005-9101-z.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"17915_CR4","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10549-011-1430-5","volume":"129","author":"EM Ozanne","year":"2011","unstructured":"Ozanne EM, Shieh Y, Barnes J, Bouzan C, Hwang ES, Esserman LJ. Characterizing the impact of 25 years of DCIS treatment. Breast Cancer Res Treat. 2011;129(1):165\u201373. https:\/\/doi.org\/10.1007\/s10549-011-1430-5.","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"17915_CR5","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1093\/jnci\/djy220","volume":"111","author":"MD Ryser","year":"2019","unstructured":"Ryser MD, Weaver DL, Zhao F, et al. Cancer outcomes in DCIS patients without locoregional treatment. J Natl Cancer Inst. 2019;111(9):952\u201360. https:\/\/doi.org\/10.1093\/jnci\/djy220.","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"17915_CR6","doi-asserted-by":"publisher","first-page":"djv263","DOI":"10.1093\/jnci\/djv263","volume":"107","author":"M Worni","year":"2015","unstructured":"Worni M, Akushevich I, Greenup R, et al. Trends in treatment patterns and outcomes for ductal carcinoma in situ. J Natl Cancer Inst. 2015;107(12):djv263. https:\/\/doi.org\/10.1093\/jnci\/djv263.","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"17915_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-026797","volume":"9","author":"ES Hwang","year":"2019","unstructured":"Hwang ES, Hyslop T, Lynch T, et al. The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS). BMJ Open. 2019;9(3):e026797. https:\/\/doi.org\/10.1136\/bmjopen-2018-026797.","journal-title":"BMJ Open"},{"issue":"16","key":"17915_CR8","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1016\/j.ejca.2015.07.017","volume":"51","author":"A Francis","year":"2015","unstructured":"Francis A, Thomas J, Fallowfield L, et al. Addressing overtreatment of screen detected DCIS; the LORIS trial. Eur J Cancer. 2015;51(16):2296\u2013303. https:\/\/doi.org\/10.1016\/j.ejca.2015.07.017.","journal-title":"Eur J Cancer"},{"issue":"12","key":"17915_CR9","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/j.ejca.2015.05.008","volume":"51","author":"LE Elshof","year":"2015","unstructured":"Elshof LE, Tryfonidis K, Slaets L, et al. Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study. Eur J Cancer. 2015;51(12):1497\u2013510. https:\/\/doi.org\/10.1016\/j.ejca.2015.05.008.","journal-title":"Eur J Cancer"},{"key":"17915_CR10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.26698","author":"ES Hwang","year":"2024","unstructured":"Hwang ES, Hyslop T, Lynch T, et al. Active monitoring with or without endocrine therapy for low-risk ductal carcinoma in situ: the COMET randomized clinical trial. JAMA. 2024. https:\/\/doi.org\/10.1001\/jama.2024.26698.","journal-title":"JAMA"},{"key":"17915_CR11","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2024.6556","author":"AH Partridge","year":"2024","unstructured":"Partridge AH, Hyslop T, Rosenberg SM, et al. Patient-reported outcomes for low-risk ductal carcinoma in situ: a secondary analysis of the COMET randomized clinical trial. JAMA Oncol. 2024. https:\/\/doi.org\/10.1001\/jamaoncol.2024.6556.","journal-title":"JAMA Oncol"},{"issue":"6","key":"17915_CR12","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.breast.2010.05.015","volume":"19","author":"R Gartner","year":"2010","unstructured":"Gartner R, Jensen MB, Kronborg L, Ewertz M, Kehlet H, Kroman N. Self-reported arm-lymphedema and functional impairment after breast cancer treatment: a nationwide study of prevalence and associated factors. Breast. 2010;19(6):506\u201315. https:\/\/doi.org\/10.1016\/j.breast.2010.05.015.","journal-title":"Breast"},{"issue":"9","key":"17915_CR13","doi-asserted-by":"publisher","first-page":"5015","DOI":"10.1245\/s10434-020-09479-2","volume":"28","author":"KL Schreiber","year":"2021","unstructured":"Schreiber KL, Zinboonyahgoon N, Flowers KM, et al. Prediction of persistent pain severity and impact 12 months after breast surgery using comprehensive preoperative assessment of biopsychosocial pain modulators. Ann Surg Oncol. 2021;28(9):5015\u201338. https:\/\/doi.org\/10.1245\/s10434-020-09479-2.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"17915_CR14","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1080\/0284186X.2017.1295167","volume":"56","author":"BG Mertz","year":"2017","unstructured":"Mertz BG, Duriaud HM, Kroman N, Andersen KG. Pain, sensory disturbances and psychological distress are common sequelae after treatment of ductal carcinoma in situ: a cross-sectional study. Acta Oncol. 2017;56(5):724\u20139. https:\/\/doi.org\/10.1080\/0284186X.2017.1295167.","journal-title":"Acta Oncol"},{"key":"17915_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f1865","volume":"346","author":"MK Mejdahl","year":"2013","unstructured":"Mejdahl MK, Andersen KG, Gartner R, Kroman N, Kehlet H. Persistent pain and sensory disturbances after treatment for breast cancer: six year nationwide follow-up study. BMJ. 2013;346:f1865. https:\/\/doi.org\/10.1136\/bmj.f1865.","journal-title":"BMJ"},{"issue":"9","key":"17915_CR16","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1097\/AJP.0000000000000156","volume":"31","author":"KG Andersen","year":"2015","unstructured":"Andersen KG, Christensen KB, Kehlet H, Bidstup PE. The effect of pain on physical functioning after breast cancer treatment: development and validation of an assessment tool. Clin J Pain. 2015;31(9):794\u2013802. https:\/\/doi.org\/10.1097\/AJP.0000000000000156.","journal-title":"Clin J Pain"},{"issue":"5","key":"17915_CR17","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.pain.2012.11.015","volume":"154","author":"KL Schreiber","year":"2013","unstructured":"Schreiber KL, Martel MO, Shnol H, et al. Persistent pain in postmastectomy patients: comparison of psychophysical, medical, surgical, and psychosocial characteristics between patients with and without pain. Pain. 2013;154(5):660\u20138. https:\/\/doi.org\/10.1016\/j.pain.2012.11.015.","journal-title":"Pain"},{"issue":"2","key":"17915_CR18","first-page":"129","volume":"23","author":"CS Cleeland","year":"1994","unstructured":"Cleeland CS, Ryan KM. Pain assessment: global use of the Brief pain inventory. Ann Acad Med Singapore. 1994;23(2):129\u201338.","journal-title":"Ann Acad Med Singapore"},{"issue":"4","key":"17915_CR19","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.ejpain.2005.06.002","volume":"10","author":"T Mendoza","year":"2006","unstructured":"Mendoza T, Mayne T, Rublee D, Cleeland C. Reliability and validity of a modified brief pain inventory short form in patients with osteoarthritis. Eur J Pain. 2006;10(4):353\u201361. https:\/\/doi.org\/10.1016\/j.ejpain.2005.06.002.","journal-title":"Eur J Pain"},{"issue":"3","key":"17915_CR20","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","volume":"34","author":"J Ware Jr","year":"1996","unstructured":"Ware J Jr, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Medical Care. 1996;34(3):220\u201333.","journal-title":"Medical Care"},{"issue":"Pt 3","key":"17915_CR21","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.2044-8260.1992.tb00997.x","volume":"31","author":"TM Marteau","year":"1992","unstructured":"Marteau TM, Bekker H. The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI). Br J Clin Psychol. 1992;31(Pt 3):301\u20136.","journal-title":"Br J Clin Psychol"},{"key":"17915_CR22","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1177\/014662167700100306","volume":"1","author":"LS Radloff","year":"1977","unstructured":"Radloff LS. The CES-D scale: a self report depression scale for research in the general population. Appl Psychol Measurement. 1977;1:385\u2013401.","journal-title":"Appl Psychol Measurement"},{"issue":"2","key":"17915_CR23","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/art.10993","volume":"49","author":"O Sangha","year":"2003","unstructured":"Sangha O, Stucki G, Liang MH, Fossel AH, Katz JN. The self-administered comorbidity questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum. 2003;49(2):156\u201363. https:\/\/doi.org\/10.1002\/art.10993.","journal-title":"Arthritis Rheum"},{"issue":"27","key":"17915_CR24","doi-asserted-by":"publisher","first-page":"5094","DOI":"10.1002\/sim.7063","volume":"35","author":"B Neelon","year":"2016","unstructured":"Neelon B, O\u2019Malley AJ, Smith VA. Modeling zero-modified count and semicontinuous data in health services research part 2: case studies. Stat Med. 2016;35(27):5094\u2013112. https:\/\/doi.org\/10.1002\/sim.7063.","journal-title":"Stat Med"},{"issue":"27","key":"17915_CR25","doi-asserted-by":"publisher","first-page":"5070","DOI":"10.1002\/sim.7050","volume":"35","author":"B Neelon","year":"2016","unstructured":"Neelon B, O\u2019Malley AJ, Smith VA. Modeling zero-modified count and semicontinuous data in health services research Part 1: background and overview. Stat Med. 2016;35(27):5070\u201393. https:\/\/doi.org\/10.1002\/sim.7050.","journal-title":"Stat Med"},{"issue":"6","key":"17915_CR26","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1177\/0962280215602290","volume":"26","author":"VA Smith","year":"2017","unstructured":"Smith VA, Preisser JS. Direct and flexible marginal inference for semicontinuous data. Stat Methods Med Res. 2017;26(6):2962\u20135. https:\/\/doi.org\/10.1177\/0962280215602290.","journal-title":"Stat Methods Med Res"},{"issue":"28","key":"17915_CR27","doi-asserted-by":"publisher","first-page":"4891","DOI":"10.1002\/sim.6263","volume":"33","author":"VA Smith","year":"2014","unstructured":"Smith VA, Preisser JS, Neelon B, Maciejewski ML. A marginalized two-part model for semicontinuous data. Stat Med. 2014;33(28):4891\u2013903. https:\/\/doi.org\/10.1002\/sim.6263.","journal-title":"Stat Med"},{"issue":"3","key":"17915_CR28","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3322\/caac.21140","volume":"62","author":"AH Partridge","year":"2012","unstructured":"Partridge AH, Elmore JG, Saslow D, McCaskill-Stevens W, Schnitt SJ. Challenges in ductal carcinoma in situ risk communication and decision-making: report from an American cancer society and national cancer institute workshop. CA Cancer J Clin. 2012;62(3):203\u201310. https:\/\/doi.org\/10.3322\/caac.21140.","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"17915_CR29","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.jpain.2010.12.005","volume":"12","author":"KG Andersen","year":"2011","unstructured":"Andersen KG, Kehlet H. Persistent pain after breast cancer treatment: a critical review of risk factors and strategies for prevention. J Pain. 2011;12(7):725\u201346. https:\/\/doi.org\/10.1016\/j.jpain.2010.12.005.","journal-title":"J Pain"},{"issue":"1","key":"17915_CR30","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jpainsymman.2012.06.016","volume":"46","author":"RR Edwards","year":"2013","unstructured":"Edwards RR, Mensing G, Cahalan C, et al. Alteration in pain modulation in women with persistent pain after lumpectomy: influence of catastrophizing. J Pain Symptom Manage. 2013;46(1):30\u201342. https:\/\/doi.org\/10.1016\/j.jpainsymman.2012.06.016.","journal-title":"J Pain Symptom Manage"},{"issue":"4","key":"17915_CR31","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/jnci\/djn010","volume":"100","author":"A Partridge","year":"2008","unstructured":"Partridge A, Adloff K, Blood E, et al. Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study. J Natl Cancer Inst. 2008;100(4):243\u201351. https:\/\/doi.org\/10.1093\/jnci\/djn010.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"17915_CR32","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.pec.2010.07.002","volume":"84","author":"S De Morgan","year":"2011","unstructured":"De Morgan S, Redman S, D\u2019Este C, Rogers K. Knowledge, satisfaction with information, decisional conflict and psychological morbidity amongst women diagnosed with ductal carcinoma in situ (DCIS). Patient Educ Couns. 2011;84(1):62\u20138. https:\/\/doi.org\/10.1016\/j.pec.2010.07.002.","journal-title":"Patient Educ Couns"},{"issue":"6","key":"17915_CR33","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1089\/15246090152543175","volume":"10","author":"LG Bluman","year":"2001","unstructured":"Bluman LG, Borstelmann NA, Rimer BK, Iglehart JD, Winer EP. Knowledge, satisfaction, and perceived cancer risk among women diagnosed with ductal carcinoma in situ. J Womens Health Gend Based Med. 2001;10(6):589\u201398. https:\/\/doi.org\/10.1089\/15246090152543175.","journal-title":"J Womens Health Gend Based Med"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17915-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-17915-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17915-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T14:17:56Z","timestamp":1762352276000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-17915-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,27]]},"references-count":33,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["17915"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-17915-4","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,27]]},"assertion":[{"value":"16 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Shoshana Rosenberg has received grant support from Pfizer\/Conquer Cancer. Dr. Kevin Hughes receives Honoraria from TME (Targeted Medical Education, genetics education and consulting), Invitae (Genetic testing), Natera (Genetic testing), Hologic (Biozorb, Breast surgery devices), Volpara (Cancer risk assessment), and Astra Zeneca (Pharmaceutical Company). He has a financial interest in CRA Health and is the Co-Creator of Ask2Me.Org. Deborah Collyar receives an honorarium from the Antibacterial Resistance Leadership Group (ARLG) and HMP Education. She also receives consulting fees from SimBioSys, MaxisHealth, Health Literacy Media (HLM), Apellis Pharmaceuticals, Inc., and Kinnate Biopharma. Dr. Plichta was the recipient of research funding by the Color Foundation and Earlier.org. She is supported in part through the NIH grant K12HD043446 (PI: Amundsen). Dr. Ann Partridge receives royalties from Wolters Kluwer and has received research support from Novartis. Dr. Shelley Hwang serves on the advisory boards for Novartis, Merck, Lumicell, and exai bio.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}